AIMS: Biomarkers are essential in the early detection of acute coronary syndromes (ACS). Serum extracellular vesicles are small vesicles in the plasma containing protein and RNA and have been shown to be involved in ACS-related processes like apoptosis and coagulation. Therefore, we hypothesized that serum extracellular vesicle protein levels are associated with ACS. METHODS AND RESULTS: Three serum extracellular vesicle proteins potentially associated with ACS were identified with differential Q-proteomics and were evaluated in 471 frozen serum samples of ACS-suspected patients presenting to the emergency department (30% of whom had an ACS). Protein levels were measured after vesicle isolation using ExoQuick. Mean serum extracellular vesicle concentration of the different proteins was compared between ACS and non-ACS patients. Selected proteins were tested in a univariate logistic regression model, as well as in a multivariate model to adjust for cardiovascular risk factors. A separate analysis was performed in men and women. In the multivariate logistic regression analysis, polygenic immunoglobulin receptor, (pIgR; OR 1.630, p=0.026), cystatin C (OR 1.641, p=0.021), and complement factor C5a (C5a, OR 1.495, p=0.025) were significantly associated with ACS, while total vesicle protein concentration was borderline significant. The association of the individual proteins with ACS was markedly stronger in men. CONCLUSIONS: These data show that serum extracellular vesicle pIgR, cystatin C, and C5a concentrations are independently associated with ACS and that there are pronounced gender differences. These observations should be validated in a large, prospective study to assess the potential role of vesicle content in the evaluation of patients suspected of having an ACS.
AIMS: Biomarkers are essential in the early detection of acute coronary syndromes (ACS). Serum extracellular vesicles are small vesicles in the plasma containing protein and RNA and have been shown to be involved in ACS-related processes like apoptosis and coagulation. Therefore, we hypothesized that serum extracellular vesicle protein levels are associated with ACS. METHODS AND RESULTS: Three serum extracellular vesicle proteins potentially associated with ACS were identified with differential Q-proteomics and were evaluated in 471 frozen serum samples of ACS-suspected patients presenting to the emergency department (30% of whom had an ACS). Protein levels were measured after vesicle isolation using ExoQuick. Mean serum extracellular vesicle concentration of the different proteins was compared between ACS and non-ACS patients. Selected proteins were tested in a univariate logistic regression model, as well as in a multivariate model to adjust for cardiovascular risk factors. A separate analysis was performed in men and women. In the multivariate logistic regression analysis, polygenic immunoglobulin receptor, (pIgR; OR 1.630, p=0.026), cystatin C (OR 1.641, p=0.021), and complement factor C5a (C5a, OR 1.495, p=0.025) were significantly associated with ACS, while total vesicle protein concentration was borderline significant. The association of the individual proteins with ACS was markedly stronger in men. CONCLUSIONS: These data show that serum extracellular vesicle pIgR, cystatin C, and C5a concentrations are independently associated with ACS and that there are pronounced gender differences. These observations should be validated in a large, prospective study to assess the potential role of vesicle content in the evaluation of patients suspected of having an ACS.
Entities:
Keywords:
ACS; acute coronary syndrome; biomarker; extracellular vesicle; protein
Authors: Robert E O'Connor; Leo Bossaert; Hans-Richard Arntz; Steven C Brooks; Deborah Diercks; Gilson Feitosa-Filho; Jerry P Nolan; Terry L Vanden Hoek; Darren L Walters; Aaron Wong; Michelle Welsford; Karen Woolfrey Journal: Circulation Date: 2010-10-19 Impact factor: 29.690
Authors: Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Timothy R Wessel; Christopher B Arant; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko Journal: J Am Coll Cardiol Date: 2006-02-07 Impact factor: 24.094
Authors: Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan P Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger Journal: Eur Heart J Date: 2005-05-25 Impact factor: 29.983
Authors: Karam M Kostner; Robert B Fahti; Colin Case; Peter Hobson; Jil Tate; Thomas H Marwick Journal: Clin Chim Acta Date: 2005-10-19 Impact factor: 3.786
Authors: Carlos M Laborde; Sergio Alonso-Orgaz; Laura Mourino-Alvarez; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas Journal: Proteome Sci Date: 2014-10-10 Impact factor: 2.480
Authors: Xavier Gallart-Palau; Aida Serra; Andrew See Weng Wong; Sara Sandin; Mitchell K P Lai; Christopher P Chen; Oi Lian Kon; Siu Kwan Sze Journal: Sci Rep Date: 2015-09-30 Impact factor: 4.379
Authors: J W Wang; C M Gijsberts; A Seneviratna; V C de Hoog; J E P Vrijenhoek; A H Schoneveld; M Y Chan; C S P Lam; A M Richards; C N Lee; A Mosterd; S K Sze; L Timmers; S K Lim; G Pasterkamp; D P V de Kleijn Journal: Neth Heart J Date: 2013-10 Impact factor: 2.380